Navin Flourine gets its highest share price target from UBS on strong CDMO, chemicals outlook
With a stronger balance sheet following its recent QIP, UBS believes Navin Fluorine is well placed to continue its capex-led expansion.
Uncategorized
Shikhara’s Rahul Chadha says RBI cut likely, FII mood hinges on tariff rollback
Shikhara Investment’s Rahul Chadha expects India’s market performance to align with the region, and sees opportunities in consumption, manufacturing and healthcare.
All you need to know about Moore Threads — The Nvidia rival whose IPO got 4,126x subscription
Moore Threads, which launched its $1.1 billion Initial Public Offer last week, has received bids worth more than 4,000 times the total number of shares on offer. The total subscription figure on the retail front ended at 4,127 times.
SML Mahindra shares jump 5% after November auto sales double from last year
On August 2, Mahindra and Mahindra Ltd. acquired 58.96% controlling stake in SML Isuzu from Japan’s Sumitomo Corporation and Isuzu Motors for ₹555 crore.
Bajaj Auto November sales meet expectations, exports grow by 14%
Shares of Bajaj Auto had also made a record high on September 27, 2024, the same day as the Nifty had made its previous top. The stock is down nearly 30% from those levels.
Peak XV Partners-backed Wakefit IPO opens December 8; here’s what investors need to know
The Bengaluru-based firm’s IPO comprises a fresh equity issue of up to ₹377.1 crore and an offer for sale (OFS) of 4.67 crore shares by existing investors.
Hindustan Zinc shares near 52-week high; Find out how big an influence is Silver
Hindustan Zinc is the only pure listed Silver play in the country as nearly 40% to 45% of its Earnings Before Interest and Tax (EBIT) comes from Silver.
GAIL’s tariff revision weighs on sentiment but CLSA sees correction as a ‘strong buying’ opportunity
Although the outcome disappointed the market in the near term, brokerage firm HSBC believes a smoother transition will support both volume and value growth.
Lupin gets USFDA nod for billion-dollar biosimilar injection used to treat cancer
As per the IQVIA MAT data, pegfilgrastim 6 mg / 0.6 mL injection for subcutaneous use in a single-dose prefilled syringe had estimated annual sales of $1,295 million in the US for the 12 months ending September 2025.
Godrej Properties emerges highest bidder for Hyderabad land parcel with ₹4,150 crore revenue potential
Godrej Properties had participated in an e-auction conducted by the Hyderabad Metropolitan Development Authority (HMDA) for the land parcel. HMDA will issue the allotment letters after following the due process.